Antitumor effect of MCC-465, pegylated liposomal doxorubicin tagged with newly developed monoclonal antibody GAH, in colorectal cancer xenografts
- Author
- HAMAGUCHI, Tetsuya1 ; MATSUMURA, Yasuhiro1 2 ; KAKIZOE, Tadao5 ; NAKANISHI, Yukihiro3 ; MURO, Kei1 ; YAMADA, Yasuhide1 ; SHIMADA, Yasuhiro1 ; SHIRAO, Kuniaki1 ; NIKI, Hisae4 ; HOSOKAWA, Saiko4 ; TAGAWA, Toshiaki4
[1] Department of Medicine, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan
[2] Investigative Treatment Division, National Cancer Center Research Institute East, 6-5-1 Kashiwanoha, Kashiwa 277-8577, Japan
[3] Department of Pathology, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan
[4] Pharmaceutical Research Division, Mitsubishi Pharma Corporation, 1000 Kamoshida-cho, Aoba-ku, Yokohama 227-0033, Japan
[5] National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan - Source
Cancer science. 2004, Vol 95, Num 7, pp 608-613, 6 p ; ref : 31 ref
- ISSN
- 1347-9032
- Scientific domain
- Medical oncology
- Publisher
- Blackwell, Tokyo
- Publication country
- Japan
- Document type
- Article
- Language
- English
- Keyword (fr)
- Antibiotique Anticancéreux Anticorps monoclonal Cancer colorectal Doxorubicine Forme libération contrôlée Hétérogreffe Hétérotransplantation Liposome Traitement Vecteur médicament Anthracyclines Appareil digestif pathologie Chirurgie Côlon pathologie DNA topoisomerase (ATP-hydrolysing) Enzyme Greffe Inhibiteur enzyme Intestin pathologie Isomerases Rectum pathologie Transplantation Tumeur maligne
- Keyword (en)
- Antibiotic Antineoplastic agent Monoclonal antibody Colorectal cancer Doxorubicin Controlled release form Heterograft Heterotransplantation Liposome Treatment Drug carrier Anthracyclins Digestive diseases Surgery Colonic disease DNA topoisomerase (ATP-hydrolysing) Enzyme Graft Enzyme inhibitor Intestinal disease Isomerases Rectal disease Transplantation Malignant tumor
- Keyword (es)
- Antibiótico Anticanceroso Anticuerpo monoclonal Cancer de colon y recto Doxorubicina Forma liberación controlada Heteroinjerto Heterotrasplante Liposoma Tratamiento Vector medicamento Antraciclinas Aparato digestivo patología Cirugía Colón patología DNA topoisomerase (ATP-hydrolysing) Enzima Injerto Inhibidor enzima Intestino patología Isomerases Recto patología Trasplantación Tumor maligno
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B13 Gastroenterology. Liver. Pancreas. Abdomen / 002B13B Stomach. Duodenum. Small intestine. Colon. Rectum. Anus / 002B13B01 Tumors
- Discipline
- Gastroenterology. Liver. Pancreas. Abdomen
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 15978545
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1111/j.1349-7006.2004.tb02495.x 
https://dx.doi.org/10.1111/j.1349-7006.2004.tb02495.x
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:34:\"10.1111\/j.1349-7006.2004.tb02495.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:145:\"Antitumor effect of MCC-465, pegylated liposomal doxorubicin tagged with newly developed monoclonal antibody GAH, in colorectal cancer xenografts\";s:9:\"\u0000*\u0000jtitle\";s:14:\"Cancer science\";s:9:\"\u0000*\u0000stitle\";s:10:\"Cancer sci\";s:7:\"\u0000*\u0000date\";s:4:\"2004\";s:9:\"\u0000*\u0000volume\";s:2:\"95\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:3:\"608\";s:8:\"\u0000*\u0000epage\";s:3:\"613\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1347-9032\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"HAMAGUCHI\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Tetsuya\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:19:\"MATSUMURA, Yasuhiro\";i:1;s:14:\"KAKIZOE, Tadao\";i:2;s:19:\"NAKANISHI, Yukihiro\";i:3;s:9:\"MURO, Kei\";i:4;s:16:\"YAMADA, Yasuhide\";i:5;s:17:\"SHIMADA, Yasuhiro\";i:6;s:15:\"SHIRAO, Kuniaki\";i:7;s:11:\"NIKI, Hisae\";i:8;s:15:\"HOSOKAWA, Saiko\";i:9;s:16:\"TAGAWA, Toshiaki\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:145:\"Antitumor effect of MCC-465, pegylated liposomal doxorubicin tagged with newly developed monoclonal antibody GAH, in colorectal cancer xenografts\";s:8:\"\u0000*\u0000place\";s:5:\"Tokyo\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:34:\"10.1111\/j.1349-7006.2004.tb02495.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:145:\"Antitumor effect of MCC-465, pegylated liposomal doxorubicin tagged with newly developed monoclonal antibody GAH, in colorectal cancer xenografts\";s:9:\"\u0000*\u0000jtitle\";s:14:\"Cancer science\";s:9:\"\u0000*\u0000stitle\";s:10:\"Cancer sci\";s:7:\"\u0000*\u0000date\";s:4:\"2004\";s:9:\"\u0000*\u0000volume\";s:2:\"95\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:3:\"608\";s:8:\"\u0000*\u0000epage\";s:3:\"613\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1347-9032\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"HAMAGUCHI\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Tetsuya\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:19:\"MATSUMURA, Yasuhiro\";i:1;s:14:\"KAKIZOE, Tadao\";i:2;s:19:\"NAKANISHI, Yukihiro\";i:3;s:9:\"MURO, Kei\";i:4;s:16:\"YAMADA, Yasuhide\";i:5;s:17:\"SHIMADA, Yasuhiro\";i:6;s:15:\"SHIRAO, Kuniaki\";i:7;s:11:\"NIKI, Hisae\";i:8;s:15:\"HOSOKAWA, Saiko\";i:9;s:16:\"TAGAWA, Toshiaki\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:145:\"Antitumor effect of MCC-465, pegylated liposomal doxorubicin tagged with newly developed monoclonal antibody GAH, in colorectal cancer xenografts\";s:8:\"\u0000*\u0000place\";s:5:\"Tokyo\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:34:\"10.1111\/j.1349-7006.2004.tb02495.x\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:34:\"10.1111\/j.1349-7006.2004.tb02495.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:145:\"Antitumor effect of MCC-465, pegylated liposomal doxorubicin tagged with newly developed monoclonal antibody GAH, in colorectal cancer xenografts\";s:9:\"\u0000*\u0000jtitle\";s:14:\"Cancer science\";s:9:\"\u0000*\u0000stitle\";s:10:\"Cancer sci\";s:7:\"\u0000*\u0000date\";s:4:\"2004\";s:9:\"\u0000*\u0000volume\";s:2:\"95\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:3:\"608\";s:8:\"\u0000*\u0000epage\";s:3:\"613\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1347-9032\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"HAMAGUCHI\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Tetsuya\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:19:\"MATSUMURA, Yasuhiro\";i:1;s:14:\"KAKIZOE, Tadao\";i:2;s:19:\"NAKANISHI, Yukihiro\";i:3;s:9:\"MURO, Kei\";i:4;s:16:\"YAMADA, Yasuhide\";i:5;s:17:\"SHIMADA, Yasuhiro\";i:6;s:15:\"SHIRAO, Kuniaki\";i:7;s:11:\"NIKI, Hisae\";i:8;s:15:\"HOSOKAWA, Saiko\";i:9;s:16:\"TAGAWA, Toshiaki\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:145:\"Antitumor effect of MCC-465, pegylated liposomal doxorubicin tagged with newly developed monoclonal antibody GAH, in colorectal cancer xenografts\";s:8:\"\u0000*\u0000place\";s:5:\"Tokyo\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:34:\"10.1111\/j.1349-7006.2004.tb02495.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:145:\"Antitumor effect of MCC-465, pegylated liposomal doxorubicin tagged with newly developed monoclonal antibody GAH, in colorectal cancer xenografts\";s:9:\"\u0000*\u0000jtitle\";s:14:\"Cancer science\";s:9:\"\u0000*\u0000stitle\";s:10:\"Cancer sci\";s:7:\"\u0000*\u0000date\";s:4:\"2004\";s:9:\"\u0000*\u0000volume\";s:2:\"95\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:3:\"608\";s:8:\"\u0000*\u0000epage\";s:3:\"613\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1347-9032\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"HAMAGUCHI\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Tetsuya\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:19:\"MATSUMURA, Yasuhiro\";i:1;s:14:\"KAKIZOE, Tadao\";i:2;s:19:\"NAKANISHI, Yukihiro\";i:3;s:9:\"MURO, Kei\";i:4;s:16:\"YAMADA, Yasuhide\";i:5;s:17:\"SHIMADA, Yasuhiro\";i:6;s:15:\"SHIRAO, Kuniaki\";i:7;s:11:\"NIKI, Hisae\";i:8;s:15:\"HOSOKAWA, Saiko\";i:9;s:16:\"TAGAWA, Toshiaki\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:145:\"Antitumor effect of MCC-465, pegylated liposomal doxorubicin tagged with newly developed monoclonal antibody GAH, in colorectal cancer xenografts\";s:8:\"\u0000*\u0000place\";s:5:\"Tokyo\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:34:\"10.1111\/j.1349-7006.2004.tb02495.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:145:\"Antitumor effect of MCC-465, pegylated liposomal doxorubicin tagged with newly developed monoclonal antibody GAH, in colorectal cancer xenografts\";s:9:\"\u0000*\u0000jtitle\";s:14:\"Cancer science\";s:9:\"\u0000*\u0000stitle\";s:10:\"Cancer sci\";s:7:\"\u0000*\u0000date\";s:4:\"2004\";s:9:\"\u0000*\u0000volume\";s:2:\"95\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:3:\"608\";s:8:\"\u0000*\u0000epage\";s:3:\"613\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1347-9032\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"HAMAGUCHI\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Tetsuya\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:19:\"MATSUMURA, Yasuhiro\";i:1;s:14:\"KAKIZOE, Tadao\";i:2;s:19:\"NAKANISHI, Yukihiro\";i:3;s:9:\"MURO, Kei\";i:4;s:16:\"YAMADA, Yasuhide\";i:5;s:17:\"SHIMADA, Yasuhiro\";i:6;s:15:\"SHIRAO, Kuniaki\";i:7;s:11:\"NIKI, Hisae\";i:8;s:15:\"HOSOKAWA, Saiko\";i:9;s:16:\"TAGAWA, Toshiaki\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:145:\"Antitumor effect of MCC-465, pegylated liposomal doxorubicin tagged with newly developed monoclonal antibody GAH, in colorectal cancer xenografts\";s:8:\"\u0000*\u0000place\";s:5:\"Tokyo\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
